Uptake of weak acid and weak base chemotherapeutic drugs by tumors is greatly influenced by the tumor extracellular / interstitial pH ( pH e ), the intracellular pH ( pH i ) maintained by the tumor cells, and by the ionization properties of the drug itself. The acid -outside plasmalemmal pH gradient in tumors acts to exclude weak base drugs like the anthracyclines, anthraquinones, and vinca alkaloids from the cells, leading to a substantial degree of ''physiological drug resistance'' in tumors. We have induced acute metabolic alkalosis in C3H tumor -bearing C3H / hen mice, by gavage and by intraperitoneal ( i.p. ) administration of NaHCO 3 .
Introduction
The extracellular pH ( pH e ) and intracellular pH ( pH i ) of tumors influence the effectiveness of chemotherapy by influencing drug uptake kinetics and the ionic equilibrium of weak acid and weak base drug molecules. Weak base drug molecules like mitoxantrone will tend to be retained in the more acidic compartments within a tumor, whereas weak acid species like chlorambucil will tend to concentrate in the more alkaline compartments [ 1, 2 ] . Electrode measurements in humans and animals reveal tumor extracellular / interstitial pH to be generally lower than the pH of normal tissue [ 3 ] , but pooled measurements of pH of normal and tumor tissue made by various investigators show some overlap [ 4 ] . In a recent review, Gerweck [ 4 ] has argued that this apparent overlap results from differences in technical variables associated with electrode measurements of tissue pH by different investigators, as well as physiological and metabolic differences between patients at the time of examination, and has resulted in an underexploitation of the pH difference between normal and tumor tissue for therapeutic purposes. Noninvasive 31 P magnetic resonance spectroscopy ( MRS ) allows the simultaneous investigation of tissue pH i from the chemical shift of inorganic phosphate ( P i ) [ 5 ] and pH e from the chemical shift of an extracellular pH probe such as 3 -aminopropylphosphonate ( 3 -APP ) [ 6 ] . MRS measurements of tumor pH i and pH e in various human tumor xenografts in mice indicate that tumor pH i is similar to or more alkaline than in normal tissue, whereas tumor pH e is more acidic than in normal tissues [ 7, 8 ] , leading to an acid -outside plasmalemmal pH gradient in tumors.
We have recently demonstrated that this acid -outside plasmalemmal pH gradient can be abolished, even reversed, in experimental tumor xenografts by chronic ad libitum administration of 200 mM sodium bicarbonate to the host mice [ 9 ] . Further, we have demonstrated that the antitumor activity of doxorubicin in an SCID mouse model of MCF -7 human breast carcinoma is enhanced by NaHCO 3 -induced tumor alkalinization [ 9 ] . Chronic administration of NaHCO 3 to mice is undesirable due to potential hypernatremia and other metabolic disorders, and is also not translatable to humans. We have investigated the feasibility of inducing acute alkalinization of tumors in a C3H mouse model by i.p. and gavage administration of NaHCO 3 to the host animals. We have also measured tumor and normal tissue pH e and pH i in mice after oral administration of NH 4 Cl to the host animals to induce acidosis. The influence of acute alkalinization of tumors on tumor response to a weak base drug, mitoxantrone, has been investigated. Mitoxantrone was chosen over doxorubicin because of its greater octanol -water partition coefficient, and because of its dual positive ionization status at physiological pH compared to the singly charged doxorubicin.
Materials and Methods

Cells and Animals Used
C3H murine mammary carcinoma tumor fragments were implanted in the mammary fat pads of 5 -to 6 -week -old female C3H / Hen mice by means of a 12G trocar. Tumor volumes were calculated from orthogonal measurements of external dimensions as ( width ) 2 Â( length ) / 2. MRS was performed on the mice once the tumors had grown to > 300 mm 3 .
Gavage Administration of NaHCO 3 /NH 4 Cl To induce acute metabolic acidosis or alkalosis by the oral route, mice were administered either 0.7 ml 1 M NH 4 Cl or 0.7 ml 1 M NaHCO 3 , respectively, by gavage. Anesthetization immediately following NH 4 Cl gavage resulted in the deaths of all three mice tested. For this reason, for MRS measurements of mice that had been administered either NH 4 Cl or NaHCO 3 by gavage, mice were anesthetized 2 hours following gavage. Control and NaHCO 3 -treated mice were anesthetized using a mix of Ketamine, Xylazine and Acepromazine ( 72 / 6 / 6 mg / kg ), whereas mice that had been administered NH 4 Cl by gavage were anesthetized with 75% of this dose, due to reduced tolerance of these mice to one or more of the components even 2 hours after the gavage. NH 4 Cl -and NaHCO 3 -treated mice were denied access to normal ad libitum water for 2 hours following gavage, at which point they were anesthetized and prepared for 31 P MRS of either tumor or hind leg tissue. pH measurements were also made on untreated control mice for comparison. Despite the reduced dose of anesthetic, the duration of anesthesia and recovery time were greater in NH 4 Cl -treated mice than in control mice that had been given the full anesthetic dose. Recovery from anesthesia was also somewhat prolonged in NaHCO 3 -treated mice compared with control mice.
Intraperitoneal Administration of NaHCO 3
For experiments involving i.p. administration of NaHCO 3 , mice were anesthetized as described earlier and administered 3 -APP ( i.p., 0.4 mlÂ0.24 M, pH 7.4 at room temperature ). A 3 / 4 -in., 24G catheter ( Elf Sanofi Inc., Overland Park, KS ), connected through a three -way valve to two 60 -cm -long, 1.58 -mm -ID polyethylene tubes ( Becton Dickinson, Parsippany, NJ ), was then inserted into the i.p. cavity of the anesthetized mouse. This set -up permitted delivery of NaHCO 3 (0.7 mlÂ1 M) at the appropriate time, or delivery of a ''booster'' dose of 3 -APP ( 0.2 mlÂ0.24 M, if required ) without moving the animal out of the magnet. The combined dead volume of the i.p. catheter and three -way valve was 0.2 ml, meaning that delivery of a booster dose of 3 -APP resulted in the delivery of an additional 0.2 ml of NaHCO 3 as well. The mouse was immobilized on a home -built MRS solenoid coil and centered in the magnet. NaHCO 3 was tolerated by anesthetized and alert C3H mice up to the maximum tested dose of 1 mlÂ1 M. It was found that i.p. NaHCO 3 enhanced the duration of the anesthesia and also increased the recovery time of C3H mice. Intraperitoneal administration of NH 4 Cl was not tolerated by anesthetized mice, although alert mice tolerated up to 1 mlÂ1 M NH 4 Cl without any fatalities ( n =4).
Localized In Vivo 31 P MR Spectroscopy
All in vivo measurements were performed at 4.7 T on a Bruker Biospec spectrometer / imager equipped with a 14 G / cm self -shielded gradient insert, using home -built solenoid coils of suitable diameter. Image -guided volume -selective 31 P MR spectra of tumors or hind leg tissue in anesthetized mice were acquired using the PRESS sequence [ 10 ] . pH e and pH i were measured from the chemical shifts of exogenous 3 -APP and endogenous P i , respectively, as described earlier [ 8 ] . For spectroscopy of tumors, 0. Chemotherapy Two groups of 6 -week -old female C3H / Hen mice ( n = 4, each ) bearing C3H tumors in the mammary fat pad ( approximately 250 mm 3 ) were used. One group was administered a single dose of 0.7 mlÂ1 M NaHCO 3 ( i.p. ) and denied access to drinking water for the next 4 hours, whereas the other group did not receive any treatment and had uninterrupted access to ad libitum water. The two groups were compared for changes in tumor growth rates to assess the influence of NaHCO 3 on tumor growth. In a separate experiment, four groups of C3H / Hen mice ( n =4, each ) bearing C3H tumors in the mammary fat pad were used. Groups A and B were administered two doses of mitoxantrone ( i.v., 6 mg / kg ) given 7 days apart, whereas groups C and D were administered a single dose of mitoxantrone ( i.v., 12 mg / kg ). Groups B and D were also administered 0.7 mlÂ1 M NaHCO 3 ( i.p. ) 2 hours before each mitoxantrone injection. NaHCO 3 -treated mice were denied access to ad libitum water for 4 hours starting with administration of the NaHCO 3 , but were allowed continuous access to solid food. Access to drinking water was restored 2 hours after drug administration. The toxicity of mitoxantrone to mice has been reported to have a marked circadian dependence, with the lowest toxicity being observed at 11 to 15 hours after light onset [ 11 ] . For this reason, mitoxantrone was administered 12 hours after light onset in all experiments.
Results 31 P MR spectra of tumor and ( normal ) hind leg tissue were acquired before and immediately following i.p. administration of NaHCO 3 to anesthetized mice placed in the magnet. Chemical shifts were calibrated against the -NTP resonance, which was set to À 10.05 ppm in all spectra. Tissue pH e and pH i were calculated from the chemical shifts of 3 -APP and P i , respectively, as explained elsewhere [ 8 ] . The 3 -APP resonance shifts upfield ( to lower parts per million ( ppm ) values ) on the 31 P MR spectrum with increasing pH, whereas the opposite is true of the P i resonance. Figure 1 shows a series of 31 P MR spectra obtained from a C3H tumor before and following NaHCO 3 administration. A slow shift over 2 hours of the P i resonance to higher chemical shifts is visible, indicating an alkalinization of tumor pH i . It can also be seen that the 3 -APP resonance shifts to lower chemical shifts, indicating an alkalinization of tumor pH e . The 3 -APP resonance tended to broaden immediately following NaHCO 3 administration. This indicates a greater heterogeneity of tumor pH e induced by NaHCO 3 administration, and suggests the presence of compartments within the tumor exhibiting differing kinetics of alkalinization in response to the NaHCO 3 . The intensities of the NTP resonances, an indicator of the energetic status of the tumors, were not significantly altered by the NaHCO 3 administration. The significant increase in the phosphocreatine resonance seen in Figure 1 was not consistently observed in all tumors. The pH i and pH e corresponding to these spectra are plotted in Figure 3B . Figure 2 shows a series of 31 P MR spectra acquired from the normal hind leg tissue of a tumor -bearing C3H mouse. A shift of the 3 -APP peak to lower ppm values is visible 45 minutes after i.p. delivery of NaHCO 3 to the mouse, indicating an increase in tissue pH e that persists through 2 hours postinjection. A small shift of the P i peak to higher ppm values is also visible by 45 minutes postinjection, indicating an increase in tissue pH i . Significant changes in the NTP peaks or in the large phosphocreatine peak ( %À 2.5 ppm ) were not observed subsequent to the NaHCO 3 injection. The pH e and pH i values corresponding to this experiment are plotted in the inset in Figure 2 . It can be seen that NaHCO 3 administration produces a small but persistent alkalinization of both pH e and pH i in hind leg tissue through at least 2 hours postinjection. Panels B to D of Figure 3 depict pH e and pH i changes in response to i.p. administration of NaHCO 3 in large C3H tumors, whereas panel A depicts the pH response of a smaller tumor. It can be seen from Figure 3A that both pH e and pH i in this smaller C3H tumor are neutral to alkaline, and do not increase further upon i.p. administration of NaHCO 3 . As seen in Figure 3B À D, resting pH e in large C3H tumors ranges from 6.1 to 6.7, and inversely corresponds to tumor size. It can also be seen that pH e in these acidic tumors increases in response to i.p. administration of NaHCO 3 . Resting pH i in the tumors shown in Figure 3B À D, was neutral to acidic ( 6.75 to 7.05 ), and increased in response to NaHCO 3 administration. Unlike the 3 -APP resonance, which is purely extracellular in origin, the P i resonance includes the contributions of both extracellular and intracellular P i . As Figure 1 . A series of 31 P MR spectra were obtained from a 975 -mm 3 C3H tumor before and after i.p. administration of 0.7 mlÂ1 M NaHCO 3 to the mouse at t = 0 minutes. Chemical shifts are calibrated against the -NTP resonance, which is set to À 10.05 ppm. By 1 hour postinjection, the pH e of the tumor is substantially raised, as indicated by the shift of the 3 -APP resonance upfield to lower ppm values, and this increase persists through 4 hours postinjection. Tumor pH i is increased to a small extent by 4 hours postinjection as well, as indicated by the shift to higher ppm values of the P i resonance.
such, the increase in pH reported by the P i resonance is partly due to the extracellular alkalinization reported independently by the 3 -APP resonance. The increases in pH indicated by the P i resonance in these tumors following NaHCO 3 administration is thus an overestimate of any increases in tumor pH i . pH e and pH i of C3H tumors were also measured in mice that had been administered either NaHCO 3 or NH 4 Cl by gavage, as well as in control mice, as explained earlier. To further investigate a possible relationship between tumor size and tumor pH e ( Figure 3 ), tumors from mice in the control group are presented in three size categories in Figure  4 . pH values for tumors in all groups of mice were analyzed by the Student's t test or by ANOVA. Although there is a downward trend to the mean, neither pH e nor pH i was statistically significantly affected by tumor size for tumors in the control group, for the tumor size ranges shown in Figure  4 ( P > .2 ). Three hours after NaHCO 3 administration by Figure 2 . A series of 31 P MR spectra were obtained from the hind leg of a C3H / Hen mouse before and after i.p. administration of 0.7 mlÂ1 M NaHCO 3 to the mouse at t = 0 minutes. Signal intensities of both the 3 -APP and P i peaks were low compared with spectra obtained from tumors. A small shift of the 3 -APP peak to lower ppm values is visible by 45 minutes postinjection, indicating alkalinization of tissue pH e . A small shift of the P i resonance to higher ppm values is also visible, indicating alkalinization of pH i . The intensities of the phosphocreatine peak ( % À 2.5 ppm ) and the NTP peaks % À 5, À 10.05, and À 18.5 ppm ) did not change significantly during the course of MRS experiment. The inset shows the calculated pH e and pH i versus time in hind leg tissue from these spectra. Both pH e and pH i are seen to increase slightly following i.p. administration of 0.7 mlÂ1 M NaHCO 3 . gavage, tumor pH i in NaHCO 3 -treated mice was not significantly different from tumor pH i in control animals ( P > .05 against tumors in all three control groups ). However, tumor pH e was significantly higher in NaHCO 3 -treated mice compared to tumors in untreated control mice in the two larger size categories ( P < .05 ). Tumor pH e in NaHCO 3 -treated mice was marginally higher than tumor pH e in the smallest group of tumors ( 688 ± 211 mm 3 ) in control mice ( P = .06 ). Both tumor pH i and tumor pH e were significantly lower in NH 4 Cl -treated mice than in control mice regardless of tumor size ( P < .03 in all cases ). pH e and pH i of normal hind leg tissue were measured in mice 3 hours after they were treated by gavage administration of either NaHCO 3 or NH 4 Cl, and in control mice ( Figure 5 ) . pH values for the three groups were analyzed by the Student's t test. Gavage administration of NaHCO 3 to mice did not significantly affect pH i ( P =.17) or pH e ( P =.5) of hind leg tissue compared to control animals. However, gavage administration of NH 4 Cl to mice did significantly lower both pH e ( P = .003 ) as well as pH i ( P = .04 ) compared with control animals.
We have previously mathematically modeled the partitioning of singly charged weak base and weak acid drugs into cells at various pH i and pH e [ 12 ] . For a doubly charged weak base drug molecule M, the following equilibria are expected for the various charged species:
Actually, there will be two distinct singly charged intermediates MH + in the above equilibrium, depending on which proton on MH 2 2 + comes off first. But the relevant protons are symmetrically located on mitoxantrone, and we have therefore shown both singly charged species as being identical in the above chemical equations. This simplification is justifiable in our situation because, at physiological pH, a drug with pK a1 of 8.25 ( such as mitoxantrone ) exists mostly in the charged forms, and the expression for intracellular -toextracellular drug ratio ( Equation 1, below ) is insensitive to the value of the acid dissociation constants for the two singly charged species. Making the assumption that the cell membrane is essentially impermeable to the charged species MH + and MH 2 2 + , and that there is a fast equilibration of the uncharged species across the cell membrane [ 12 ] , we can compute the following relationship for the intracellular -to -extracellular ratio of total drug: Figure 4 . Average pH e and pH i values ( ± SD ) from C3H tumors in control mice, and in mice that were administered either NaHCO 3 or NH 4 Cl ( 0.7 mlÂ1 M ) by gavage. Tumors from control mice were separated into three categories based on size. Neither pH e nor pH i was significantly affected by tumor size for tumors in the control group ( P > .2 ). Tumor pH i in NaHCO 3 -treated mice was not significantly different from tumor pH i in control animals ( P > .05 against tumors in all three control groups ). # Tumor pH e was significantly higher in NaHCO 3 -treated mice compared to tumors in untreated control mice in the two larger size categories ( P < .05 ). Tumor pH e in NaHCO 3 -treated mice was marginally higher than tumor pH e in the smallest group of tumors ( 688 ± 211 mm 3 ) in control mice ( P = .06 ). *Both tumor pH i and tumor pH e were significantly lower in NH 4 Cl -treated mice than in control mice regardless of tumor size ( P < .03 in all cases ). Figure 5 . Average pH e and pH i values ( ± SD ) from normal hind leg tissue in control mice, and in mice that were administered either NaHCO 3 or NH 4 Cl ( 0.7 mlÂ1 M ) by gavage. Gavage administration of NaHCO 3 did not result in significant changes in either pH e ( P = .5 ) or pH i ( P = .17 ). *Gavage administration of NH 4 Cl resulted in a considerable drop in pH e ( P = .003 ) as well as pH i ( P = .04 ) of hind leg tissue in treated mice compared with control mice.
Analogous calculations can be performed for a singly charged weak acid drug AH, for which the following equilibrium can be expected:
and the following relationship can be derived for the intracellular -to -extracellular drug ratio: Figure 3B and inset in Figure 2 ), we predict from Equation 1 that the partitioning of mitoxantrone will increase by 1.5 -fold in normal tissue and five -fold in tumor tissue, and this is depicted in Figure 6 . Thus, a net therapeutic gain of 3.3 -fold is predicted when chemotherapy with mitoxantrone is preceded by NaHCO 3 -induced alkalinization of the host animal. Calculations for a hypothetical weak acid with pK a 6.0 predict that the acidosis induced by gavage administration of NH 4 Cl ( Figures 4 and 5 ) will drive two -fold more drug into cells of hind leg tissue, but only 1.2 -fold more drug into cells in the tumor ( Figure 6 ). Thus, acidosis induced in the host animal by NH 4 Cl gavage may actually reduce the effectiveness of a weak acid drug. Of course, drug dosage is usually limited by cardiac and bone -marrow toxicities and not toxicity to muscle, but reliable MRS measurements of pH e in these organs could not be obtained. Tumor acidification by gavage administration of NH 4 Cl appears to be not tumor -selective and will not result in any gain in therapeutic index for treatment with weak acid drugs. Kuin et al. [ 13 ] report that induction of moderate degrees of hyperglycemia combined with i.p. administration of m -iodobenzylguanidine ( MIBG ), an inhibitor of mitochondrial respiration, lowers tumor pH e but not pH i in RIF -1 tumors in C3H mice. Their protocol seeks to enhance the degree of aerobic glycolysis exhibited by tumor cells and may offer greater potential to selectively acidify tumors. The influence of NaHCO 3 -induced acute metabolic alkalosis itself on tumor growth, as well as on tumor response to mitoxantrone therapy, are shown in Figure  7A À C. In an initial experiment, a group of four mice bearing C3H tumors that were 200 to 300 mm 3 in volume was administered a single i.p. injection of 0.7 mlÂ1 M NaHCO 3 and denied access to ad libitum water for the following 4 hours. The mean tumor volumes of the NaHCO 3 -treated group and an untreated control group are compared in Figure  7A . No significant change in tumor growth rates were observed as a result of the NaHCO 3 treatment. To test the influence of NaHCO 3 -induced alkalosis on tumor response to mitoxantrone therapy, four groups of four C3H tumorbearing mice each were treated with either two doses of 6 mg / kg mitoxantrone ( groups A and B ) or a single dose of 12 mg / kg mitoxantrone ( groups C and D ). Groups B and D were also administered 0.7 mlÂ1 M NaHCO 3 ( i.p. ) 2 hours before each mitoxantrone injection. The kinetics of tumor alkalinization observed in Figure 3B À D indicate that significant tumor alkalinization occurs a minimum of 2 hours following NaHCO 3 administration, and this was the reason for the delay of 2 hours between NaHCO 3 and mitoxantrone injections administered to groups B and D. When the two doses of 6 mg / kg were administered 4 days apart to NaHCO 3 -treated mice, a significant enhancement of tumor response to mitoxantrone was observed, but this was accompanied by substantial loss of body weight in the mice and increased rates of mortality compared to mice treated with mitoxantrone alone ( data not shown ). Intraperitoneal 7 .35 / 7.6 / 6.8 -and inserted into Equations 1 and 2 to obtain the drug partition ratios shown here. Pretreatment with NaHCO 3 ( i.p. ) is predicted to result in a five -fold enhancement in uptake of mitoxantrone into tumor tissue compared to tumor tissue in an untreated host, but only a 1.5 -fold increase in uptake of drug into normal tissue in the NaHCO 3 -treated animal compared with normal tissue in an untreated animal. Thus, the chemotherapeutic index of mitoxantrone can potentially be increased 3.3 -fold by NaHCO 3 pretreatment of the host animal. However, acidosis induced by gavage administration of NH 4 Cl to the host animal is not tumor specific, resulting in a two -fold increase in uptake of a weak acid drug of pK a 6 into normal tissue and only a 1.2 -fold increase in uptake into tumor tissue. Thus, the chemotherapeutic index of a weak acid drug is predicted to be reduced by gavage administration of NH 4 Cl.
administration of NaHCO 3 did not, however, alter the LD 50 of mitoxantrone when it was administered as a single dose ( data not shown ). A gap of 7 days between successive doses of 6 mg / kg mitoxantrone was well tolerated by NaHCO 3 -treated mice, and this was used in subsequent experiments. Figure 7B shows the tumor growth curves of mice in groups A and B. The arrows in Figure 7B and C indicate the days of treatment. The error bars ( standard deviation ) in Figure 7B and C reflect not just the heterogeneity in response to treatment within each group, but also the pretreatment heterogeneity in tumor volumes within each treatment group. No deaths were recorded in any of the 4 groups during the course of the experiment. A tumor growth delay ( TGD ) of 9 days was calculated for group A, whereas a TGD of 15 days was calculated for tumors in NaHCO 3 -treated mice from group B ( Figure 7B ). Group C mice were treated with a single 12 mg / kg dose of mitoxantrone resulting in a TGD of 9 days, whereas a TGD of 16 days was calculated for the mice in group D that were cotreated with 12 mg / kg mitoxantrone and NaHCO 3 ( Figure 7C ). Thus, cotreatment with NaHCO 3 produced a significant enhancement of TGD following mitoxantrone therapy when it was given either as a single dose or as two fractionated doses separated by 7 days. A comparison of the TGDs shown in Figure 7B and C indicates that the TGD induced by mitoxantrone therapy is not significantly altered by dose fractionation, regardless of whether the therapy also included NaHCO 3 treatment or not. Log 10 cell kills [ 14 ] were calculated for groups C and D: mitoxantrone therapy in the absence of NaHCO 3 produced a 0.9 log 10 cell kill, whereas combined NaHCO 3 -mitoxantrone therapy results in a log 10 cell kill of 1.56, indicating a greater than 4.5 -fold increase in cell kill effected by treatment with NaHCO 3 before treatment with mitoxantrone in this tumor model.
Discussion
Previously, we have reported that chronic supplementation of ad libitum water provided to MCF -7 tumor -bearing SCID mice with 200 mM NaHCO 3 resulted in alkalinization of tumor pH e by 0.8 pH units whereas increasing tumor pH i by only 0.2 pH units [ 9 ] . Chronic sodium bicarbonate therapy is undesirable because it presents a substantial sodium load to the animal, and is also impractical from the standpoint of translation of this protocol to humans. Acute administration of NaHCO 3 by the oral and intravenous routes have been reported to cause a small but significant increase in blood pH in humans [ 15, 16 ] , although measurements of tissue pH in humans following NaHCO 3 administration are not found in the literature. In our C3H tumor model, i.p. administration of 2.3 to 2.9 g / kg NaHCO 3 to tumor -bearing C3H mice resulted in increases of 0.4 to 0.6 pH units in tumor pH e and 0.1 to 0.25 pH units in tumor pH i for periods of more than 3 to 6 hours, with only small changes in pH e and pH i of control normal hind leg tissue. Theoretical calculations of mitoxantrone uptake into cells at these measured pH e and pH i values indicate that a gain in therapeutic index of up to 3.3 -fold is possible with NaHCO 3 pretreatment. Treatment of C3H tumors with 12 mg / kg mitoxantrone results in a log 10 cell kill of 0.9, whereas combined NaHCO 3 -mitoxantrone therapy results in a log 10 cell kill of 1.56. Kozin and Gerweck [ 17 ] have shown that acid -adapted Chinese hamster ovary ( CHO ) cells cultured at pH 6.8 maintain a pH i similar to that of normal CHO cells cultured at pH 7.4. Acid -adapted CHO cells were found to be 14 -fold more resistant to mitoxantrone than normal CHO cells. Theoretical calculations predict that the increased ( pH i À pH e ) gradient in acid -adapted CHO cells will result in a two -fold decrease in cellular mitoxantrone uptake, which is significantly less than the 14 -fold reduction in mitoxantrone toxicity to these cells, suggesting that other pH -sensitive mechanisms also play a role in potentiating mitoxantrone action on these cells. Thus, in our in vivo experiments, although increased uptake of mitoxantrone by tumor cells in NaHCO 3 -treated mice due to elimination of the acid -outside plasmalemmal pH gradient would appear to be the primary mechanism by which tumor response to mitoxantrone is enhanced, other explanations cannot be ruled out. In our protocol, treatment with hyperosmolal NaHCO 3 was accompanied by denial of ad libitum water to the mice for 4 hours and this could conceivably have reduced renal / biliary clearance of mitoxantrone from the mice, thereby increasing drug retention in the entire animal. This possible mechanism is currently under investigation. An alternate explanation for the pH dependencies of the toxicities of various ionic and nonionic drugs to tumor cells has been proposed by Vukovic and Tannock [ 18 ] . They have observed that a lower proportion of cells with acidic pH i are in G 1 phase than at alkaline pH i , leading to diminished sensitivity to the drugs mitoxantrone ( a weak base ) and paclitaxel ( a zwitterion ) in acidic cells [ 18 ] . In our experiments, NaHCO 3 treatment increased not only tumor pH e , but also tumor pH i . Tumor pH e measurements using MRS imaging ( MRSI ) reveal a heterogeneity in pH e [ 19 ] that might conceivably lead to heterogeneity in tumor pH i as well. Thus, although the volume -averaged pH i values in Figure  3B À D range from 6.75 to 7.05, there might exist pockets of cells in these tumors that chronically experience even lower pH i . Cells in such pockets may be quiescent, making them resistant to antimitotic therapies, and alkalinization using NaHCO 3 may bring them into G 1 phase and sensitize them to drug bound to their DNA. In this context, it is relevant to note that although free mitoxantrone disappears from the blood in mice within 1 hour of intravenous administration, drug has been reported to remain bound to intracellular targets beyond 48 hours [ 20 ] . For such a cell cycle -related mechanism of drug enhancement to be active, tumor pH e would need to remain higher than normal for several hours following NaHCO 3 administration. We have observed that anesthetized mice remain alkalotic for at least up to 6 hours following NaHCO 3 administration. The kinetics of recovery from NaHCO 3 loading are likely different in alert mice, but some effects of the NaHCO 3 are present even 24 hours later: we have observed that 24 hours following a single i.p. dose of NaHCO 3 , mice exhibit delayed recovery from the ketamine / xylazine / acepromazine anesthetic compared with untreated control mice. We have not made pH measurements on mice 24 hours after NaHCO 3 administration, but if tissue alkalinization does indeed persist out to 24 h, this may be long enough to cause quiescent tumor cells to re -enter G 1 phase and become susceptible to bound drug that may have been administered 24 hours earlier. Acute treatment with NaHCO 3 did not, however, alter the tumor growth rate in this model.
In conclusion, oral administration of NH 4 Cl resulted in a significant acidification of both pH e and pH i in tumors as well as in control hind leg tissue in C3H mice. Theoretical calculations of weak acid drug partitioning into tumor and normal tissue cells show that the non -tumor -specific nature of NH 4 Cl -induced acidosis may actually reduce the chemotherapeutic index of a weak acid drug. However, pretreatment of tumor -bearing mice with NaHCO 3 results in a significant enhancement of tumor response to mitoxantrone, although the exact mechanism by which this occurs remains to be elucidated. Also requiring further investigation is the mechanism of increased toxicity of mitoxantrone to NaHCO 3 -treated C3H mice when the drug is administered as two doses of 6 mg / kg given 4 days apart. This increased toxicity to NaHCO 3 -treated mice, vis -a -vis mice treated with mitoxantrone alone, was not observed when the two doses of 6 mg / kg mitoxantrone were separated by 7 days, or when the drug was administered as a single dose of 12 mg / kg. Intraperitoneally administered NaHCO 3 did not alter the LD 50 of mitoxantrone to C3H mice when it was administered as a single dose. Metabolic alkalosis can be induced in humans as well, and small increases in blood pH have been reported following oral administration of NaHCO 3 [ 16 ] , intravenous NaHCO 3 [ 15 ] , intravenous Carbicarb ( an equimolar mix of Na 2 CO 3 and NaHCO 3 ) [ 15 ] , and oral administration of the loop diuretic furosemide [ 21 ] . Additionally, oral administration of NaHCO 3 [ 22 ] or the carbonic anhydrase inhibitor acetazolamide [ 23 ] has also been reported to achieve significant alkalinization of urine in humans, and this may be exploited for enhancement of therapies of certain bladder and renal tumors that are treated using drug cocktails containing vinca and anthracycline weak base drugs [ 12 ] . Techniques such as MRS and MRSI make it possible to measure tissue pH noninvasively, allowing for a determination of the effects of agents like NaHCO 3 , carbicarb and furosemide on tumor pH in humans. Demonstrable tumorselective alkalinization by one or more of these agents may permit their use in humans to enhance tumor response to weak base drugs.
